Using state-of-the-art technologies, such as genome, transcriptome, and epigenome analyses [67], study of the generation of iPS cells from patients with Werner syndrome and the correction of the WRN gene by the CRISPR/Cas9-mediated methods [68] will create new treatments for patients with Werner syndrome. The gene discussed is WRN; the disease is Werner syndrome.